GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people…
New research from Karolinska Institutet demonstrates a link between inflammatory bowel disease and faster cognitive decline among dementia patients. The study, which is published in…
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor…
In a study published in Alzheimer’s & Dementia, a team led by Dr. Sha Feng from the Shenzhen Institute of Advanced Technology of the Chinese…
Scientists know that many proteins and pathways are involved in the development and progression of neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease and frontotemporal…
Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s,…
The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts to identify patterns in neurodegenerative disease. Sifting through roughly…
The term dementia is used to describe various debilitating neurological disorders characterized by a progressive loss of memory and a decline in mental abilities. Estimates…
Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found that the drug…
A new treatment that uses music therapy on dementia wards could improve care and support for some of the NHS’s most vulnerable patients.